New Approach to Assessing MRD in Acute Leukemia New Approach to Assessing MRD in Acute Leukemia

Minimal residual disease, a benchmark for identifying patients who are at risk for relapse, is typically done using flow cytometry. Next-generation sequencing now refines the process with additional mutations thrown into the mix.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news